Key Points
- Liquidia insider Rajeev Saggar sold 50,000 shares on August 19 at an average price of $74.06, generating approximately $3.70 million and reducing his holdings by 26.01% to 142,265 shares.
- Liquidia reported quarterly revenue of $171.68 million, up 1,842.1% year over year and above estimates, but EPS of $0.74 narrowly missed the $0.76 consensus forecast.
- Analyst sentiment is mixed: the stock has a consensus “Hold” rating and a $98.08 average price target, while shares recently opened at $75.33 and institutional investors owned 64.54% of the company.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Rajeev Saggar sold 29,534 shares of the firm's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $76.84, for a total value of $2,269,392.56. Following the completion of the transaction, the insider owned 142,265 shares of the company's stock, valued at approximately $10,931,642.60. The trade was a 17.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Rajeev Saggar also recently made the following trade(s):
- On Wednesday, August 19th, Rajeev Saggar sold 50,000 shares of Liquidia stock. The stock was sold at an average price of $74.06, for a total transaction of $3,703,000.00.
- On Monday, July 13th, Rajeev Saggar sold 9,926 shares of Liquidia stock. The stock was sold at an average price of $71.51, for a total transaction of $709,808.26.
Liquidia Trading Up 1.3%
Liquidia stock opened at $75.33 on Thursday. The company has a market capitalization of $6.74 billion, a price-to-earnings ratio of 54.99 and a beta of 0.58. The business's fifty day simple moving average is $79.35 and its two-hundred day simple moving average is $55.93. Liquidia Corporation has a 12 month low of $21.15 and a 12 month high of $93.61. The company has a current ratio of 2.31, a quick ratio of 2.12 and a debt-to-equity ratio of 0.63.
Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm had revenue of $171.68 million for the quarter, compared to analysts' expectations of $168.48 million. During the same period last year, the company posted ($0.49) earnings per share. The business's revenue for the quarter was up 1842.1% compared to the same quarter last year. As a group, equities analysts predict that Liquidia Corporation will post 2.57 earnings per share for the current fiscal year.
Institutional Trading of Liquidia
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. bought a new position in shares of Liquidia during the 4th quarter valued at about $25,000. Covestor Ltd grew its holdings in Liquidia by 41.9% during the 4th quarter. Covestor Ltd now owns 1,216 shares of the company's stock valued at $42,000 after buying an additional 359 shares in the last quarter. NewEdge Advisors LLC bought a new stake in Liquidia in the 2nd quarter worth approximately $25,000. Globeflex Capital L P purchased a new stake in shares of Liquidia during the 2nd quarter worth approximately $175,000. Finally, Fluent Financial LLC purchased a new stake in Liquidia during the second quarter valued at $287,000. 64.54% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
LQDA has been the subject of several recent analyst reports. Jefferies Financial Group restated a "buy" rating and issued a $60.00 price target on shares of Liquidia in a research note on Monday, May 11th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Liquidia in a research note on Friday, July 17th. Wall Street Zen lowered Liquidia from a "strong-buy" rating to a "buy" rating in a report on Saturday, June 27th. Oppenheimer set a $75.00 price objective on shares of Liquidia in a research note on Friday, June 5th. Finally, Lifesci Capital cut Liquidia from an "outperform" rating to a "hold" rating and set a $90.00 price target on the stock. in a report on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $98.08.
Read Our Latest Report on Liquidia
Liquidia Company Profile
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
